ProKidney Corp. - Class A Ordinary Shares (PROK) earnings
PROK earnings moved a median of +0.72% by the close. Quarterly and annual PROK reports and results, each read against the price at its own news timestamp. Back to the PROK overview →
18 measured PROK earnings events.
Where these PROK earnings landedvs 18 measured PROK earnings reactions
| Middle 50% of PROK earnings reactions | -3.74% to +4.41% |
|---|---|
| Median reaction (to close) | +0.72% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 PROK earnings events with a measured close landed between -3.74% and +4.41%; 67% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PROKIDNEY CORP. For: Mar 31 | SEC filing · Form 10-Q | -0.79% | +3.58% | |
| ProKidney Reports First Quarter 2026 Financial Results and Business Highlights | Press release | -1.24% | +2.79% | |
| Form 10-K PROKIDNEY CORP. For: Dec 31 | SEC filing · Form 10-K | -8.01% | -5.34% | |
| Form 10-Q PROKIDNEY CORP. For: Sep 30 | SEC filing · Form 10-Q | -1.80% | +0.72% | |
| ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates | Press release | -1.80% | +0.72% | |
| Form 10-Q PROKIDNEY CORP. For: Jun 30 | SEC filing · Form 10-Q | +3.52% | +4.41% | |
| ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates | Press release | +3.52% | +4.41% | |
| Form 10-Q PROKIDNEY CORP. For: Mar 31 | SEC filing · Form 10-Q | -0.07% | +14.19% | |
| ProKidney Reports First Quarter 2025 Financial Results and Business Highlights | Press release | -0.07% | +14.19% | |
| Form 10-K PROKIDNEY CORP. For: Dec 31 | SEC filing · Form 10-K | -4.22% | -5.86% | |
| Form 10-Q PROKIDNEY CORP. For: Sep 30 | SEC filing · Form 10-Q | -0.47% | -2.36% | |
| ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting | Press release | -0.05% | -4.21% | |
| Form 10-Q PROKIDNEY CORP. For: Jun 30 | SEC filing · Form 10-Q | -2.61% | -9.56% | |
| ProKidney Reports Business Updates and Second Quarter 2024 Financial Results | Press release | -2.30% | +0.46% | |
| Form 10-Q PROKIDNEY CORP. For: Mar 31 | SEC filing · Form 10-Q | +2.07% | +6.21% | |
| ProKidney Reports Business Updates and First Quarter 2024 Financial Results | Press release | +6.79% | +6.04% | |
| Form 10-K PROKIDNEY CORP. For: Dec 31 | SEC filing · Form 10-K | +0.36% | +0.72% | |
| Form 10-Q PROKIDNEY CORP. For: Sep 30 | SEC filing · Form 10-Q | +1.34% | -6.71% |
Keep exploring
More PROK: analyst actions → · SEC filings → · PROK overview →